With the clinical trials of various cancer immunotherapies being announced lately, I found this a really interesting resource for some context on this research field
There’s some interesting discussion of balancing tech transfer and deployment vs fleshing out the science. 2009 didn’t turn out to be the year of the cancer vaccine, but I think digging into the reasons why is interesting to the HN crowd
Also, I learned the concept of cancer immunotherapy has been around a long time!
> The notion that the immune system could be enlisted to launch an attack on an existing tumor has been around at least since the late 1800s, when the New York City–based physician William Coley noticed that metastases at several sites regressed in a sarcoma patient after she developed a bacterial incision-wound infection. Coley's attempts to exploit this discovery were handicapped by the then-crude state of knowledge.
1 comment
[ 3.2 ms ] story [ 9.4 ms ] threadThere’s some interesting discussion of balancing tech transfer and deployment vs fleshing out the science. 2009 didn’t turn out to be the year of the cancer vaccine, but I think digging into the reasons why is interesting to the HN crowd
Also, I learned the concept of cancer immunotherapy has been around a long time!
> The notion that the immune system could be enlisted to launch an attack on an existing tumor has been around at least since the late 1800s, when the New York City–based physician William Coley noticed that metastases at several sites regressed in a sarcoma patient after she developed a bacterial incision-wound infection. Coley's attempts to exploit this discovery were handicapped by the then-crude state of knowledge.